SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-014835
Filing Date
2023-03-30
Accepted
2023-03-30 16:23:12
Documents
5
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 DEF14A ny20007879x1_def14a.htm DEF 14A 716372
2 logo_vera.jpg GRAPHIC 23942
3 ny20003095x1_sigfordyce.jpg GRAPHIC 20319
4 ny20007879x1_pc01.jpg GRAPHIC 524752
5 ny20007879x1_pc02.jpg GRAPHIC 482588
  Complete submission text file 0001140361-23-014835.txt   2164778
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40407 | Film No.: 23781008
SIC: 2834 Pharmaceutical Preparations